Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis

被引：0
|
作者：
Noriyoshi Miura
Keiichiro Mori
Hadi Mostafaei
Fahad Quhal
Reza Sari Motlagh
Mohammad Abufaraj
Benjamin Pradere
Abdulmajeed Aydh
Ekaterina Laukhtina
David D’Andrea
Takashi Saika
Shahrokh F. Shariat
机构：
[1] Comprehensive Cancer Center,Department of Urology
[2] Medical University of Vienna,Department of Urology
[3] Ehime University Graduate School of Medicine,Department of Urology
[4] The Jikei University School of Medicine,Research Center for Evidence based Medicine
[5] Tabriz University of Medical Sciences,Department of Urology
[6] King Fahad Specialist Hospital,Division of Urology, Department of Special Surgery, Jordan University Hospital
[7] The University of Jordan,Department of Urology
[8] University Hospital of Tours,Institute for Urology and Reproductive Health
[9] King Faisal Medical City,Department of Urology
[10] Sechenov University,Department of Urology
[11] Weill Cornell Medical College,Department of Urology, Second Faculty of Medicine
[12] University of Texas Southwestern,undefined
[13] Karl Landsteiner Institute of Urology and Andrology,undefined
[14] Charles University,undefined
[15] European Association of Urology Research Foundation,undefined
来源：
International Journal of Clinical Oncology | 2020年 / 25卷
关键词：
Prostate cancer; Testosterone; Meta-analysis; Androgen receptor-targeted agents; Castration-resistant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1881 / 1891
页数：10
相关论文
共 50 条
  • [31] Revealing Prognostic Value of Skeletal-Related Parameters in Metastatic Castration-Resistant Prostate Cancer on Overall Survival: A Systematic Review and Meta-Analysis of Randomized Controlled Trial
    Tong, Tongyu
    Lei, Hanqi
    Guan, Yupeng
    Yang, Xiangwei
    Liao, Guolong
    Li, Yamei
    Jiang, Donggen
    Pang, Jun
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [32] Prognostic value of ECOG performance status and Gleason score in the survival of castration-resistant prostate cancer: a systematic review
    Chen, Wen-Jun
    Kong, Da-Ming
    Li, Liang
    ASIAN JOURNAL OF ANDROLOGY, 2021, 23 (02) : 163 - 169
  • [33] Clinical implication of prognostic and predictive biomarkers for castration-resistant prostate cancer: a systematic review
    Shengri Tian
    Zhen Lei
    Zuo Gong
    Zhonghai Sun
    Dongyuan Xu
    Minhu Piao
    Cancer Cell International, 20
  • [34] Clinical implication of prognostic and predictive biomarkers for castration-resistant prostate cancer: a systematic review
    Tian, Shengri
    Lei, Zhen
    Gong, Zuo
    Sun, Zhonghai
    Xu, Dongyuan
    Piao, Minhu
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [35] Comparison of effectiveness and safety outcomes of abiraterone versus enzalutamide in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis
    Wang, Xin
    Yang, Hui
    Wang, Shihui
    Hu, Xiaopeng
    Yu, Xiaojia
    Wang, Wei
    Zhang, Xiaodong
    Liu, Lihong
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2020, 23 : 451 - U12
  • [36] Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients-a systematic review and meta-analysis
    Fazekas, Tamas
    Szeles, Adam D.
    Teutsch, Brigitta
    Csizmarik, Anita
    Vekony, Balint
    Varadi, Alex
    Koi, Tamas
    Lang, Zsolt
    Acs, Nandor
    Kopa, Zsolt
    Hegyi, Peter
    Hadaschik, Boris
    Gruenwald, Viktor
    Nyirady, Peter
    Szarvas, Tibor
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (04) : 665 - 672
  • [37] Addition of Olaparib to the New Hormonal Agent Regimen for Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
    Warli, Syah Mirsya
    Velaro, Adrian Joshua
    Firsty, Naufal Nandita
    Tala, Zaimah Zulkarnaini
    WORLD JOURNAL OF ONCOLOGY, 2023, 14 (06) : 518 - 528
  • [38] Oncological Response and Predictive Biomarkers for the Checkpoint Inhibitors in Castration-Resistant Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis
    Fahmy, Omar
    Alhakamy, Nabil A.
    Khairul-Asri, Mohd G.
    Ahmed, Osama A. A.
    Fahmy, Usama A.
    Fresta, Claudia G.
    Caruso, Giuseppe
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (01):
  • [39] PARP inhibitor-based treatment in metastatic, castration-resistant prostate cancer (mCRPC): A systematic review and meta-analysis
    Roberto, Michela
    Di Civita, Mattia Alberto
    Marinelli, Daniele
    Torchia, Andrea
    Cara, Nertila
    Maltese, Giulia
    Speranza, Iolanda
    Santini, Daniele
    BJUI COMPASS, 2025, 6 (01):
  • [40] Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
    Keiichiro Mori
    Hadi Mostafaei
    Benjamin Pradere
    Reza Sari Motlagh
    Fahad Quhal
    Ekaterina Laukhtina
    Victor M. Schuettfort
    Mohammad Abufaraj
    Pierre I. Karakiewicz
    Takahiro Kimura
    Shin Egawa
    Shahrokh F. Shariat
    International Journal of Clinical Oncology, 2020, 25 : 1892 - 1900
12345